Activity Overview | This Webcast contains video and downloadable slides from “Unsolved Puzzles in Early Breast Cancer,” a Satellite Symposium held at the 12th St Gallen International Breast Cancer Conference. |
Faculty | Chair
Ian Smith, MD, FRCP, FRCPE
Royal Marsden Hospital
London, United Kingdom
Faculty
Javier Cortés, MD, PhD
Vall d’Hebron University Hospital
Barcelona, Spain
Nadia Harbeck, MD, PhD
University of Cologne
Cologne, Germany
Sunil Verma, MD, MSEd, FRCPC
Toronto Sunnybrook Regional Cancer Center
Toronto, Ontario, Canada
Giuseppe Viale, MD, FRCPath
European Institute of Oncology and
University of Milan
Milan, Italy |
|
|
 |
|
Expert Discussion
|
 |
|
Downloadable Slides
|
|
 |
Topics | How should pCR data from neoadjuvant trials be used in clinical practice?
Nadia Harbeck, MD, PhD
Can dual blockade stand alone without chemotherapy in the management of HER2-amplified breast cancer?
Sunil Verma, MD, MSEd, FRCPC
What do breast oncologists need to know about biosimilar monoclonal antibodies?
Javier Cortés, MD, PhD
How should discordant results of rebiopsy during disease progression impact therapeutic decision making?
Giuseppe Viale, MD, FRCPath |
Target Audience | This educational activity is designed for medical oncologists and other healthcare providers involved and/or interested in the treatment of patients with breast cancer.
The information in this activity is intended for healthcare professionals based outside of the United States. You will be asked to provide your credentials before accessing the Webcast and slides. This activity may contain information on products outside the approved indications where you practice. |
|
|
|
Support | Financial support for this activity has been provided by F. Hoffmann-La Roche Ltd.
|
|
